Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 125

The DOI matches its Crossref record.

Calcium carbonate vaterite particles for drug delivery : Advances and challenges

Trushina, Daria B., Borodina, Tatiana N., Belyakov, Sergei, Antipina, Maria N.·2022·Materials Today Advances

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mtadv.2022.100214

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 93

  1. He, 2019, Adapting liposomes for oral drug delivery, Acta Pharm. Sin. B., 9, 36, 10.1016/j.apsb.2018.06.005 · DOI · Paper page
  2. Cohn, 2015, The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: a low-value intervention?, Gynecol. Oncol. Rep., 13, 47, 10.1016/j.gore.2015.06.009 · doi:10.1016/j.gore.2015.06.009
  3. Ngan, 2016, A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: an updated review, Arch. Pharm. Pract., 7, 1
  4. Borba, 2018, Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections, Mycoses, 61, 754, 10.1111/myc.12801 · DOI
  5. Vikulina, 2020, Naturally derived nano- and micro- drug delivery vehicles: halloysite, vaterite and nanocellulose, New J. Chem., 10.1039/C9NJ06470B · DOI
  6. Paravastu, 2019, Role of nanocomposites in drug delivery, GSC Biol. Pharm. Sci., 8, 10.30574/gscbps.2019.8.3.0150 · doi:10.30574/gscbps.2019.8.3.0150
  7. Cavallaro, 2018, Mesoporous inorganic nanoscale particles for drug adsorption and controlled release, Ther. Deliv., 9, 287, 10.4155/tde-2017-0120 · DOI
  8. Maleki Dizaj, 2019, An update on calcium carbonate nanoparticles as cancer drug/gene delivery system, Expet Opin. Drug Deliv., 16, 331, 10.1080/17425247.2019.1587408 · DOI
  9. Zhao, 2015, A preloaded amorphous calcium carbonate/doxorubicin@silica nanoreactor for pH-responsive delivery of an anticancer drug, Angew. Chem. Int. Ed., 54, 919, 10.1002/anie.201408510 · DOI · Paper page
  10. Balabushevich, 2019, Mucin adsorption on vaterite CaCO3 microcrystals for the prediction of mucoadhesive properties, J. Colloid Interface Sci., 545, 330, 10.1016/j.jcis.2019.03.042 · DOI
  11. Balabushevich, 2018, Self-assembled mucin-containing microcarriers via hard templating on CaCO3crystals, Micromachines, 9, 1, 10.3390/mi9060307 · DOI
  12. Marchenko, 2018, Mesoporous particle-based microcontainers for intranasal delivery of imidazopyridine drugs, J. Microencapsul., 35, 657, 10.1080/02652048.2019.1571642 · DOI
  13. Binevski, 2019, Bio-friendly encapsulation of superoxide dismutase into vaterite CaCO3 crystals. Enzyme activity, release mechanism, and perspectives for ophthalmology, Colloids Surf. B Biointerfaces, 181, 437, 10.1016/j.colsurfb.2019.05.077 · DOI
  14. Gusliakova, 2018, Use of submicron vaterite particles serves as an effective delivery vehicle to the respiratory portion of the lung, Front. Pharmacol., 9, 1, 10.3389/fphar.2018.00559 · DOI
  15. Svenskaya, 2019, A simple non-invasive approach towards efficient transdermal drug delivery based on biodegradable particulate system, ACS Appl. Mater. Interfaces, 10.1021/acsami.9b04305 · DOI
  16. Liu, 2017, Oral delivery of insulin using CaCO3-based composite nanocarriers with hyaluronic acid coatings, Mater. Lett., 188, 263, 10.1016/j.matlet.2016.10.117 · doi:10.1016/j.matlet.2016.10.117
  17. Volodkin, 2014, CaCO3 templated micro-beads and -capsules for bioapplications, Adv. Colloid Interface Sci., 207, 306, 10.1016/j.cis.2014.04.001 · DOI · Paper page
  18. German, 2018, High-efficiency freezing-induced loading of inorganic nanoparticles and proteins into micron- and submicron-sized porous particles, Sci. Rep., 8, 17763, 10.1038/s41598-018-35846-x · doi:10.1038/s41598-018-35846-x
  19. Petrov, 2008, Protein-calcium carbonate coprecipitation: a tool for protein encapsulation, Biotechnol. Prog., 21, 918, 10.1021/bp0495825 · doi:10.1021/bp0495825
  20. Vikulina, 2018, The mechanism of catalase loading into porous vaterite CaCO3 crystals by co-synthesis, Phys. Chem. Chem. Phys., 20, 8822, 10.1039/C7CP07836F · DOI
  21. Trushina, 2014, CaCO3 vaterite microparticles for biomedical and personal care applications, Mater. Sci. Eng. C, 45, 644, 10.1016/j.msec.2014.04.050 · DOI · Paper page
  22. Elbaz, 2020, Controlled synthesis of calcium carbonate nanoparticles and stimuli-responsive multi-layered nanocapsules for oral drug delivery, Int. J. Pharm., 574, 118866, 10.1016/j.ijpharm.2019.118866 · DOI
  23. Qiu, 2012, Calcium carbonate microspheres as carriers for the anticancer drug camptothecin, Mater. Sci. Eng. C, 32, 2634, 10.1016/j.msec.2012.08.026 · doi:10.1016/j.msec.2012.08.026
  24. Dunuweera, 2017, Encapsulation of anticancer drug cisplatin in vaterite polymorph of calcium carbonate nanoparticles for targeted delivery and slow release, Biomed. Phys. Eng. Expr., 4
  25. Wu, 2014, Multi-drug delivery system based on alginate/calcium carbonate hybrid nanoparticles for combination chemotherapy, Colloids Surf. B Biointerfaces, 123, 498, 10.1016/j.colsurfb.2014.09.047 · DOI
  26. Wang, 2006, Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery, Int. J. Pharm., 308, 160, 10.1016/j.ijpharm.2005.11.004 · DOI · Paper page
  27. Charnay, 2004, Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property, Eur. J. Pharm. Biopharm., 57, 533, 10.1016/j.ejpb.2003.12.007 · DOI · Paper page
  28. Feoktistova, 2020, Bioactivity of catalase loaded into vaterite CaCO3 crystals via adsorption and co-synthesis, Mater. Des., 185, 108223, 10.1016/j.matdes.2019.108223 · DOI
  29. She, 2012, Encapsulation of basic fibroblast growth factor by polyelectrolyte multilayer microcapsules and its controlled release for enhancing cell proliferation, Biomacromolecules, 13, 2174, 10.1021/bm3005879 · DOI
  30. Kakran, 2015, Layered polymeric capsules inhibiting the activity of RNases for intracellular delivery of messenger RNA, J. Mater. Chem. B., 3, 5842, 10.1039/C5TB00615E · DOI
  31. Svenskaya, 2013, Anticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizer, Biophys. Chem., 182, 11, 10.1016/j.bpc.2013.07.006 · doi:10.1016/j.bpc.2013.07.006
  32. Svenskaya, 2014, Calcium carbonate microparticles containing a photosensitizer photosens: preparation, ultrasound stimulated dye release, and in vivo application, Nanotechnol. Russ., 9, 398, 10.1134/S1995078014040181 · doi:10.1134/s1995078014040181
  33. Borodina, 2008, Entrapment of herbal extracts into biodegradable microcapsules, Biochem. Suppl. Ser. B Biomed. Chem., 2, 176
  34. Abalymov, 2020, Alkaline phosphatase delivery system based on calcium carbonate carriers for acceleration of ossification, ACS Appl. Bio Mater., 10.1021/acsabm.0c00053 · doi:10.1021/acsabm.0c00053
  35. Trushina, 2016, Size-controlled synthesis of vaterite calcium carbonate by the mixing method: aiming for nanosized particles, Cryst. Growth Des., 16, 1311, 10.1021/acs.cgd.5b01422 · DOI · Paper page
  36. Svenskaya, 2018, Key parameters for size- and shape-controlled synthesis of vaterite particles, Cryst. Growth Des., 18, 331, 10.1021/acs.cgd.7b01328 · DOI
  37. Donatan, 2016, Loading capacity versus enzyme activity in anisotropic and spherical calcium carbonate microparticles, ACS Appl. Mater. Interfaces, 8, 14284, 10.1021/acsami.6b03492 · DOI
  38. Parakhonskiy, 2014, Macromolecule loading into spherical, elliptical, star-like and cubic calcium carbonate carriers, ChemPhysChem, 15, 2817, 10.1002/cphc.201402136 · DOI
  39. Vikulina, 2021, Mesoporous additive-free vaterite CaCO3 crystals of untypical sizes: from submicron to Giant, Mater. Des., 197, 109220, 10.1016/j.matdes.2020.109220 · DOI
  40. Dong, 2017, Using porous CaCO3/hyaluronic acid nanocages to accommodate hydrophobic photosensitizer in aqueous media for photodynamic therapy, Colloid. Surf. A Physicochem. Eng. Asp., 516, 190, 10.1016/j.colsurfa.2016.12.027 · DOI
  41. Trushina, 2018, Immobilization of photoditazine on vaterite porous particles and analysis of the system stability in model media, Tech. Phys., 63, 1387, 10.1134/S1063784218090220 · doi:10.1134/s1063784218090220
  42. Balabushevich, 2015, Protein loading into porous CaCO 3 microspheres: adsorption equilibrium and bioactivity retention, Phys. Chem. Chem. Phys., 17, 2523, 10.1039/C4CP04567J · doi:10.1039/c4cp04567j
  43. Hassani, 2013, Lysozyme encapsulation into nanostructured CaCO3 microparticles using a supercritical CO2 process and comparison with the normal route, J. Mater. Chem. B., 1, 4011, 10.1039/c3tb20467g · DOI
  44. Osada, 2020, Protein adsorption behaviors on siloxane-containing vaterite particles, Mater. Lett., 264, 127280, 10.1016/j.matlet.2019.127280 · doi:10.1016/j.matlet.2019.127280
  45. Shi, 2018, A facile and efficient strategy to encapsulate the model basic protein lysozyme into porous CaCO3, J. Mater. Chem. B., 6, 4205, 10.1039/C8TB00312B · DOI
  46. Choukrani, 2020, Biocompatible superparamagnetic sub-micron vaterite particles for thermo-chemotherapy: from controlled design to in vitro anticancer synergism, Mater. Sci. Eng. C, 106, 110226, 10.1016/j.msec.2019.110226 · DOI
  47. Feoktistova, 2020, Inter-protein interactions govern protein loading into porous vaterite CaCO 3 crystals, Phys. Chem. Chem. Phys., 22, 9713, 10.1039/D0CP00404A · DOI
  48. Rivera-Gil, 2009, Intracellular processing of proteins mediated by biodegradable polyelectrolyte capsules, Nano Lett., 9, 4398, 10.1021/nl902697j · DOI · Paper page
  49. Kilic, 2017, Formulation for oral delivery of lactoferrin based on bovine serum albumin and tannic acid multilayer microcapsules, Sci. Rep., 7, 44159, 10.1038/srep44159 · DOI
  50. Aniol, 2011, [Evaluation of antiepileptic effects of cortexin in a model of convulsions], Zh. Nevrol. Psikhiatr. Im. S S Korsakova, 111
  51. Ueno, 2005, Drug-incorporating calcium carbonate nanoparticles for a new delivery system, J. Contr. Release, 103, 93, 10.1016/j.jconrel.2004.11.015 · DOI · Paper page
  52. Song, 2018, Preparation and characterization of calcium carbonate microspheres and their potential application as drug carriers, Mol. Med. Rep., 17, 8403
  53. Peng, 2013, Preparation of hierarchical mesoporous CaCO3 by a facile binary solvent approach as anticancer drug carrier for etoposide, Nanoscale Res. Lett., 8, 321, 10.1186/1556-276X-8-321 · DOI
  54. Svenskaya, 2016, Photodynamic therapy platform based on localized delivery of photosensitizer by vaterite submicron particles, Colloids Surf. B Biointerfaces, 146, 171, 10.1016/j.colsurfb.2016.05.090 · doi:10.1016/j.colsurfb.2016.05.090
  55. Lengert, 2019, Mesoporous carriers for transdermal delivery of antifungal drug, Mater. Lett., 248, 211, 10.1016/j.matlet.2019.04.028 · doi:10.1016/j.matlet.2019.04.028
  56. Gusliakova, 2019, Spectral monitoring of naftifine immobilization into submicron vaterite particles, Opt Spectrosc., 126, 539, 10.1134/S0030400X19050114 · doi:10.1134/s0030400x19050114
  57. Gusliakova, 2021, Transdermal platform for the delivery of the antifungal drug naftifine hydrochloride based on porous vaterite particles, Mater. Sci. Eng. C, 119, 111428, 10.1016/j.msec.2020.111428 · DOI
  58. Wu, 2016, Biotinylated carboxymethyl chitosan/CaCO3 hybrid nanoparticles for targeted drug delivery to overcome tumor drug resistance, RSC Adv., 6, 69083, 10.1039/C6RA04219H · DOI
  59. Gong, 2015, Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy, Langmuir, 31, 5115, 10.1021/acs.langmuir.5b00542 · doi:10.1021/acs.langmuir.5b00542
  60. Sudareva, 2018, Two-level delivery systems based on CaCO 3 cores for oral administration of therapeutic peptides, J. Microencapsul., 35, 619, 10.1080/02652048.2018.1559247 · doi:10.1080/02652048.2018.1559247
  61. Peng, 2010, Sustained delivery of doxorubicin by porous CaCO3 and chitosan/alginate multilayers-coated CaCO3 microparticles, Colloid. Surf. A Physicochem. Eng. Asp., 353, 132, 10.1016/j.colsurfa.2009.11.004 · DOI · Paper page
  62. Wang, 2016, Gelatin-assisted synthesis of vaterite nanoparticles with higher surface area and porosity as anticancer drug containers in vitro, Chempluschem, 81, 194, 10.1002/cplu.201500515 · DOI
  63. Ying, 2014, Intracellular pH-sensitive delivery CaCO 3 nanoparticles templated by hydrophobic modified starch micelles, RSC Adv., 4, 10841, 10.1039/C3RA47501H · doi:10.1039/c3ra47501h
  64. Li, 2020, Porous calcite CaCO3 microspheres: preparation, characterization and release behavior as doxorubicin carrier, Colloids Surf. B Biointerfaces, 186, 1, 10.1016/j.colsurfb.2019.110720 · doi:10.1016/j.colsurfb.2019.110720
  65. Bosio, 2014, Synthesis and characterization of CaCO3-biopolymer hybrid nanoporous microparticles for controlled release of doxorubicin, Colloids Surf. B Biointerfaces, 123, 158, 10.1016/j.colsurfb.2014.09.011 · DOI
  66. Zou, 2013, In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery, J. Pharmacol. Sci., 102, 126, 10.1002/jps.23341 · DOI
  67. Balabushevich, 2019, Hybrid CaCO3-mucin crystals: effective approach for loading and controlled release of cationic drugs, Mater. Des., 182, 108020, 10.1016/j.matdes.2019.108020 · DOI
  68. Xue, 2020, Magnetic drug-loaded osteoinductive Fe3O4/CaCO3 hybrid microspheres system: efficient for sustained release of antibiotics, J. Phys. D Appl. Phys.
  69. Singh, 2018, Drug delivery of sulphanilamide using modified porous calcium carbonate, Colloid Polym. Sci., 296, 1711, 10.1007/s00396-018-4392-x · DOI
  70. Vergaro, 2015, Synthesis of biocompatible polymeric nano-capsules based on calcium carbonate: a potential cisplatin delivery system, J. Inorg. Biochem., 153, 284, 10.1016/j.jinorgbio.2015.10.014 · DOI
  71. V German, 2021, Advanced technique for in situ Raman spectroscopy monitoring of the freezing-induced loading process, Langmuir, 37, 1365, 10.1021/acs.langmuir.0c02593 · DOI
  72. Parakhonskiy, 2019, Magnetic and silver nanoparticle functionalized calcium carbonate particles—dual functionality of versatile, movable delivery carriers which can surface-enhance Raman signals, J. Appl. Phys., 126, 10.1063/1.5111973 · DOI
  73. Novoselova, 2019, Focused ultrasound-mediated fluorescence of composite microcapsules loaded with magnetite nanoparticles: In vitro and in vivo study, Colloids Surf. B Biointerfaces, 181, 680, 10.1016/j.colsurfb.2019.06.025 · DOI
  74. Demina, 2021, Highly-magnetic mineral protein-tannin vehicles with anti-breast cancer activity, Mater. Chem. Front., 5, 10.1039/D0QM00732C · doi:10.1039/d0qm00732c
  75. Som, 2016, Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo, Nanoscale, 8, 12639, 10.1039/C5NR06162H · DOI · Paper page
  76. Som, 2019, Calcium carbonate nanoparticles stimulate tumor metabolic reprogramming and modulate tumor metastasis, Nanomedicine, 14, 169, 10.2217/nnm-2018-0302 · DOI
  77. Kim, 2013, Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles, Cancer Lett., 334, 311, 10.1016/j.canlet.2012.07.011 · DOI
  78. Zhang, 2018, Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas, Nano Res., 11, 4806, 10.1007/s12274-018-2066-0 · DOI
  79. Sun, 2019, pH-dependent and cathepsin B activable CaCO3 nanoprobe for targeted in vivo tumor imaging, Int. J. Nanomed., 14, 4309, 10.2147/IJN.S201722 · DOI
  80. Sudareva, 2020, CaCO3 vaterites as components of target drug delivery systems, Cell Ther. Transplant, 9, 13, 10.18620/ctt-1866-8836-2020-9-2-13-19 · DOI
  81. Popryadukhin, 2021, Morphology of porous CACO3 vaterites as components of target drug delivery systems in rat muscle tissue, Cell Tissue Biol., 15, 208, 10.1134/S1990519X21020061 · doi:10.1134/s1990519x21020061
  82. Haruta, 2003, An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers, Diabetes Technol. Therapeut., 5, 1, 10.1089/152091503763816409 · DOI
  83. Ishikawa, 2002, Insoluble powder formulation as an effective nasal drug delivery system, Pharm. Res. (N. Y.), 19, 1097, 10.1023/A:1019881706159 · DOI
  84. Bukreeva, 2011, Calcium carbonate and titanium dioxide particles as a basis for container fabrication for brain delivery of compounds, Dokl. Phys. Chem., 440, 165, 10.1134/S001250161109003X · doi:10.1134/s001250161109003x
  85. Borodina, 2018, A novel formulation of zolpidem for direct nose-to-brain delivery: synthesis, encapsulation and intranasal administration to mice, J. Pharm. Pharmacol., 70, 1164, 10.1111/jphp.12958 · DOI
  86. Alkilani, 2015, Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum, Pharmaceutics, 7, 438, 10.3390/pharmaceutics7040438 · DOI · Paper page
  87. Genina, 2016, In vivo optical monitoring of transcutaneous delivery of calcium carbonate microcontainers, Biomed. Opt Express, 7, 2082, 10.1364/BOE.7.002082 · doi:10.1364/boe.7.002082
  88. Utz, 2019, Targeted photosensitizer delivery: a prospective approach to vitiligo photochemotherapy, Vestn. Dermatol. Venerol., 95, 21, 10.25208/0042-4609-2019-95-1-21-29 · doi:10.25208/0042-4609-2019-95-1-21-29
  89. Svenskaya, 2020, Enhanced topical psoralen–ultraviolet A therapy via targeting to hair follicles, Br. J. Dermatol., 182, 1479, 10.1111/bjd.18800 · doi:10.1111/bjd.18800
  90. Zhao, 2019, Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects, Int. J. Pharm., 570, 118638, 10.1016/j.ijpharm.2019.118638 · DOI
  91. Zhao, 2012, Alginate modified nanostructured calcium carbonate with enhanced delivery efficiency for gene and drug delivery, Mol. Biosyst., 8, 753, 10.1039/C1MB05337J · doi:10.1039/c1mb05337j
  92. Zhao, 2010, Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy, Small, 6, 2436, 10.1002/smll.201000903 · doi:10.1002/smll.201000903
  93. Decuzzi, 2005, A theoretical model for the margination of particles within blood vessels, Ann. Biomed. Eng., 33, 179, 10.1007/s10439-005-8976-5 · DOI · Paper page

Metadata

Authors
Trushina, D. B., Borodina, T. N., Belyakov, S., & Antipina, M. N.
Venue
Materials Today Advances
Publisher
Elsevier BV
Published
2022-06
Volume
14
Pages
100214
ISSN
2590-0498
Cited by
125
References
0
Language
en
Licence
Funders
  • Ministry of Science and Higher Education of the Russian Federation
  • I.M. Sechenov First Moscow State Medical University
  • Russian Science Foundation (21-74-10058)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Calcium carbonate vaterite particles for drug delivery : Advances and challenges. https://app.cochat.ai/papers/10.1016/j.mtadv.2022.100214
The paper
Trushina, D. B., Borodina, T. N., Belyakov, S., & Antipina, M. N. (2022). Calcium carbonate vaterite particles for drug delivery : Advances and challenges. Materials Today Advances. https://doi.org/10.1016/j.mtadv.2022.100214

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.